CRMP-3 Polyclonal Antibody

    • 货号:YT1117
    • 应用:WB;ELISA
    • 种属:Human;Mouse;Rat
      • 靶点:
      • CRMP-3
      • 基因名称:
      • DPYSL4
      • 蛋白名称:
      • Dihydropyrimidinase-related protein 4
      • Human Swiss Prot No:
      • O14531
      • Mouse Swiss Prot No:
      • O35098
      • 免疫原:
      • The antiserum was produced against synthesized peptide derived from human DPYSL4. AA range:91-140
      • 特异性:
      • CRMP-3 Polyclonal Antibody detects endogenous levels of CRMP-3 protein.
      • 组成:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • 来源:
      • Polyclonal, Rabbit,IgG
      • 稀释:
      • WB 1:500 - 1:2000. ELISA: 1:10000. Not yet tested in other applications.
      • 纯化工艺:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • 浓度:
      • 1 mg/ml
      • 储存:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • 其他名称:
      • DPYSL4;CRMP3;ULIP4;Dihydropyrimidinase-related protein 4;DRP-4;Collapsin response mediator protein 3;CRMP-3;UNC33-like phosphoprotein 4;ULIP-4
      • 实测条带:
      • 62kD
      • 背景:
      • disease:Antibodies against post-translationally modified DPYSL4, also called anti-CV2 autoantibodies, are present in sera from patients with paraneoplastic neurological diseases (PND). PND are disorders of the nervous system associated with various systemic cancers which are not a direct result of the tumor mass or metastasis, but attributed to remote effects of the cancer.,function:Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration.,PTM:Phosphorylated upon DNA damage, probably by ATM or ATR.,similarity:Belongs to the DHOase family. Hydantoinase/dihydropyrimidinase subfamily.,subunit:Homotetramer, and heterotetramer with CRMP1, DPYSL2, DPYSL3 or DPYSL5. Interacts with PLEXA1.,
      • 功能:
      • disease:Antibodies against post-translationally modified DPYSL4, also called anti-CV2 autoantibodies, are present in sera from patients with paraneoplastic neurological diseases (PND). PND are disorders of the nervous system associated with various systemic cancers which are not a direct result of the tumor mass or metastasis, but attributed to remote effects of the cancer.,function:Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal growth cone collapse and cell migration.,PTM:Phosphorylated upon DNA damage, probably by ATM or ATR.,similarity:Belongs to the DHOase family. Hydantoinase/dihydropyrimidinase subfamily.,subunit:Homotetramer, and heterotetramer with CRMP1, DPYSL2, DPYSL3 or DPYSL5. Interacts with PLEXA1.,
      • 细胞定位:
      • Cytoplasm .
      • 组织表达:
      • Brain,Fetal brain,Retina,
      • 产品图片
      • Western Blot analysis of LOVO cells using CRMP-3 Polyclonal Antibody
      • Western blot analysis of lysates from LOVO and HT-29 cells, using DPYSL4 Antibody. The lane on the right is blocked with the synthesized peptide.
      • Western blot analysis of the lysates from RAW264.7cells using DPYSL4 antibody.